Comparison between Arohan Financial Services IPO and INDOCO REMEDIES IPO.
Arohan Financial Services IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while INDOCO REMEDIES IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
| Arohan Financial Services IPO | INDOCO REMEDIES IPO | |
|---|---|---|
| Logo |  | |
| Issue Category | Mainboard | Mainboard |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | BSE, NSE | BSE, NSE |
| Lead Managers | SBI Capital Markets Ltd. Motilal Oswal Investment Advisors Ltd. Dam Capital Advisors Ltd. | |
| Registrar | MUFG Intime India Pvt.Ltd. | |
| Market Maker | ||
| DRHP | DRHP  | |
| RHP | ||
| Final Prospectus | Final Prospectus | |
| Anchor Investor | ||
| IPO Allotment URL |
The total issue size of Arohan Financial Services IPO is up to ₹0.00 Cr whereas the issue size of the INDOCO REMEDIES IPO is up to ₹73.50 Cr. The final issue price of Arohan Financial Services IPO is and of INDOCO REMEDIES IPO is ₹245.00 per share.
| Arohan Financial Services IPO | INDOCO REMEDIES IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹220.00 per share | |
| Issue Price (Upper) | ₹245.00 per share | |
| Issue Price (Final) | ₹245.00 per share | |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | ||
| Fresh Issue Size | 0 shares | 30,00,000 shares |
| Fresh Issue Size (Amount) | up to ₹600.00 Cr | up to ₹73.50 Cr |
| OFS Issue Size | 4,04,37,529 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 0 shares | 30,00,000 shares |
| Issue Size Total (Amount) | up to ₹0.00 Cr | up to ₹73.50 Cr |
Arohan Financial Services IPO opens on , while INDOCO REMEDIES IPO opens on Dec 17, 2004. The closing date of Arohan Financial Services IPO and INDOCO REMEDIES IPO is , and Dec 23, 2004, respectively.
Arohan Financial Services IPO P/E ratio is , as compared to INDOCO REMEDIES IPO P/E ratio of .
| Arohan Financial Services IPO | INDOCO REMEDIES IPO | ||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| ||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 14.16 | 79.75 | |||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 59.51 | ||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | |||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | |||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 5.57 | ||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 5.57 | ||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 2.32 | ||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹6.88 | ||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 5.42 | ||||||||||||||||||||||||||||||||||||||||||||||
In the Arohan Financial Services IPO Retail Individual Investors (RII) are offered 0 shares while in INDOCO REMEDIES IPO retail investors are offered 0 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Arohan Financial Services IPO and 15,00,000 shares in INDOCO REMEDIES IPO.
| Arohan Financial Services IPO | INDOCO REMEDIES IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | 0 shares |
| Market Maker Reservation | 0 shares | 0 shares |
| QIB | 0 shares | 15,00,000 shares |
| NII | 0 shares | 7,50,000 shares |
| RII | 0 shares | 7,50,000 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 0 shares | 30,00,000 shares |
Arohan Financial Services IPO subscribed in total, whereas INDOCO REMEDIES IPO subscribed .
